Shots:
- Health Canada has approved Denoza (denosumab injection), a biosimilar version of Prolia
- Denoza is approved for the treatment of osteoporosis in postmenopausal women and in men at high risk of fracture. It is also authorized for all other indications of the reference biologic, as detailed in the Product Monograph
- Denoza will be available in a prefilled syringe format
Ref: Apotex | Image: Apotex | Press Release
Related News:- Apotex Receives Health Canada Approval for Aflivu (Biosimilar, Eylea)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
